secwatch.observer — SEC 8-K summary
======================================

Issuer:     OSR Holdings, Inc. (OSRH)
CIK:        0001840425
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0001193125-24-256062
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve extension of Bellevue Life Sciences SPAC deadline to Feb 2025; 44% of shares redeemed
--------------------------------------------------------------------------------

- Charter amended to extend business combination deadline from Nov 14, 2024 to Feb 14, 2025.
- Charter amended to remove net tangible asset requirement to avoid penny stock rules.
- 1,766,469 shares (approx. 44% of outstanding) tendered for redemption.
- Five existing directors re-elected at annual meeting.
- Quorum was 71.24% of outstanding shares; proposals approved overwhelmingly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840425/000119312524256062/0001193125-24-256062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840425/000119312524256062/d812587d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-256062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer